Fineotex Chemical / Q4-FY26

Read the quarter in context.

A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Positive2026-05-01Back to FCL

Revenue

₹314 Cr

verified against source

Revenue YoY

162%

reported change

EBITDA

Pending

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
Revenue (₹ Cr)PositiveWatchNegative
2 actual records
Actual quarterly Revenue (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q2 FY26: 138 · Watch source sentiment · 2025-10-30Q2 FY26Q4 FY26: 314 · Positive source sentiment · 2026-05-01Q4 FY26314138
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

Fineotex Chemical delivered a stellar Q4 FY26, with revenue surging 162% YoY to ₹314 crore and PAT jumping 118% to ₹44 crore, driven by the December 2025 acquisition of Crude Chem Technologies (CCT) and strong organic textile chemical growth. The US oilfield chemicals business contributed ~₹165 crore in Q4, with management confident of scaling to $200 million revenue by FY28 (revised from 2030). Consolidated EBITDA margin stood at 14%, with a target of 18-20% in the near term. The company is doubling CCT's manufacturing capacity and has already deployed $7 million in capex. Textile volumes grew 15% YoY, supported by improving export demand. Risks include working capital pressure (79 days) and global logistics disruptions, though management views these as manageable. The strong balance sheet (₹300+ crore cash) supports further inorganic opportunities.

Colored figures show movement against the previous available record.

Guidance to track

  • Management revised the CCT revenue target from 2030 to FY28, with Q4 FY26 as the baseline run-rate of ~$90-100 million.
  • Management expects blended EBITDA margins to improve to 18-20% in the near term, possibly within FY27.
  • CCT's manufacturing capacity is being doubled with $7 million capex already deployed; new machines being installed.
  • Agreement to acquire an additional 25% stake from founders by January 2028, increasing ownership to ~79-80%.

Risks flagged

  • Working capital cycle increased to 79 days (85 days for CCT) due to global logistics disruptions and raw material shortages, which could strain cash flows.
  • Management acknowledged container shortages and freight cost increases, which may impact margins if not fully passed through.
  • Rapid capacity expansion and technology transfer to CCT may face operational hiccups, though management is confident.
  • CCT's growth is tied to US oil and gas activity; any downturn in drilling or regulatory changes could impact demand.

Key quotes

  • The quarter four numbers are the base numbers. It's not reflecting that this is all about it and this is just a base which has been set.
  • The wallet share increase with the kind of customers we have right now... can easily go to 5x.
  • I would not be at all surprised if we don't touch that numbers... I will be rather surprised if we don't touch it.

Research modules

Go one layer deeper.